Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants [Phase 3]
A Phase 3 trial evaluating Eupolio (IPV) for safety, long-term protection, and booster effects in primary vaccination schedules, including a…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine [Phase 4]
A Phase 4 clinical trial update assessing immunogenicity of intramuscular Sabin Inactivated Poliovirus Vaccine (sIPV) and non-inferiority of…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers [Phase 4]
Phase 4 trial update on sequential vaccination with inactivated poliovirus vaccines (Sabin strains) produced on Vero cells from different ma…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Tool Kit to Improve Vaccine Confidence in the Philippines [NA]
A clinical trial update describing a toolkit intended to improve vaccine confidence in the Philippines, sponsored by the University of Toron…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule [Phase 2]
A Phase 2 trial comparing a trivalent Sabin-strain inactivated poliovirus vaccine to conventional Salk IPV in healthy infants at 6, 10, and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Confirmatory Study of BK1310 in Healthy Infants [Phase 3]
A Phase 3 confirmatory trial of BK1310 in healthy infants evaluating protection against tetanus, diphtheria, pertussis, poliomyelitis, and b…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants [Phase 3]
Phase 3 clinical trial evaluating safety and immunogenicity of sequential vaccination with Sabin Inactivated Poliomyelitis Vaccine (Vero Cel…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) [Phase 4]
This ClinicalTrials.gov entry outlines a Phase 4 study evaluating the immunogenicity of different primary immunization schedules using inact…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults [Phase 1]
A Phase 1 study evaluating the safety and immunogenicity of the recombinant trivalent poliomyelitis vaccine (Sf-RVN Cell) in healthy adults …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 safety and immunogenicity study of a pentavalent DTwP-HepB-Hib-IPV vaccine in Indonesian infants; the t…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Immunogenicity nOPV2 With and Without bOPV [Phase 2]
Phase 2 trial evaluating the immunogenicity of the novel oral polio vaccine type 2 (nOPV2) with and without the bivalent OPV (bOPV); study c…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age [Phase 2]
Phase 2 trial to evaluate the immunogenicity of LR20062 versus control in healthy infants at 2, 4, and 6 months of age. The study targets pr…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines [Phase 1]
Phase 1 study of novel oral poliomyelitis vaccines for serotypes 1 and 3. The trial has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants [NA]
This clinical trial is evaluating the safety and immunogenicity of a pentavalent DTaP-IPV/Hib vaccine in 2-month-old Chinese infants; the st…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV [Phase 3]
This document reports a Phase 3 clinical trial evaluating the immunogenicity and safety of a hexavalent vaccine that contains a reduced-dose…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children [Phase 4]
A Phase 4 trial evaluates whether vaccination campaigns using measles and oral polio vaccines influence general hospital admissions and mort…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 [Phase 4]
Phase 4 clinical trial evaluating pharyngeal immunity to Poliovirus Type-2 has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants [Phase 3]
Results from a Phase 3 trial assessing safety and immunogenicity of nOPV2 at different intervals in infants have been completed and posted (…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Phase IV Study of Concomitant Administration of the sIPV and HepA [Phase 4]
Phase IV trial update evaluating concomitant administration of Sabin Inactivated Poliovirus Vaccine (sIPV) and Hepatitis A vaccine; status i…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine [NA]
A completed clinical trial comparing immune responses from two vaccination schedules using the inactivated polio vaccine to prevent poliomye…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Community Engagement and Conditional Incentives to Accelerate Polio [NA]
A completed clinical trial update from Aga Khan University focused on community engagement and conditional incentives to accelerate polio im…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants [Phase 3]
Phase 3 trial update on safety and lot consistency immunogenicity of Sabin inactivated poliovirus vaccine (sIPV) in adults, children, infant…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama [Phase 2]
A Phase 2 clinical trial update for a novel Type 3 oral poliomyelitis vaccine conducted in Panama for poliomyelitis.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally [Phase 2]
Phase 2 trial comparing immunogenicity of inactivated poliovirus vaccine administered intramuscularly versus intradermally.